Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417268 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Eszter Boglárka Lőrincz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Influenza, Human, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, National Laboratory of Virology in Hungary, MEYS CR.
Abstract (Originalsprache)
In the shadow of SARS-CoV-2, influenza seems to be an innocent virus, although new zoonotic influenza viruses evolved by mutations may lead to severe pandemics. According to WHO, there is an urgent need for better antiviral drugs. Blocking viral hemagglutinin with multivalent N-acetylneuraminic acid derivatives is a promising approach to prevent influenza infection. Moreover, dual inhibition of both hemagglutinin and neuraminidase may result in a more powerful effect. Since both viral glycoproteins can bind to neuraminic acid, we have prepared three series of amphiphilic self-assembling 2-thio-neuraminic acid derivatives constituting aggregates in aqueous medium to take advantage of their multivalent effect. One of the series was prepared by the azide-alkyne click reaction, and the other two by the thio-click reaction to yield neuraminic acid derivatives containing lipophilic tails of different sizes and an enzymatically stable thioglycosidic bond. Two of the three bis-octyl derivatives produced proved to be active against influenza viruses, while all three octyl derivatives bound to hemagglutinin and neuraminidase from H1N1 and H3N2 influenza types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
- National Centre for Biomolecular Research, Masaryk University, 611 37 Brno, Czech Republic.
- Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
- Department of Biochemistry, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic.
- Department of Applied Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.
ORCID-Profile: Mihály Herczeg, Josef Houser, Lieve Naesens, Michaela Wimmerová, Anikó Borbás, Ilona Bereczki
Förderung
- National Research, Development and Innovation Office
- National Laboratory of Virology in Hungary
- MEYS CR
- European Regional Development Fund-Project
- National Research, Development, and Innovation Office of Hungary
Zitieren
APA
Lőrincz, E. B., Herczeg, M., Houser, J., Rievajová, M., Kuki, Á., Malinovská, L., Naesens, L., Wimmerová, M., Borbás, A., Herczegh, P., & Bereczki, I. (2023). Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417268
Vancouver
Lőrincz EB, Herczeg M, Houser J, Rievajová M, Kuki Á, Malinovská L, et al. Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417268
BibTeX
@article{Lrincz2023,
author = {Lőrincz, Eszter Boglárka and Herczeg, Mihály and Houser, Josef and Rievajová, Martina and Kuki, Ákos and Malinovská, Lenka and Naesens, Lieve and Wimmerová, Michaela and Borbás, Anikó and Herczegh, Pál and Bereczki, Ilona},
title = {Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417268}
}
EUVIMED